Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays

被引:23
作者
Kopecky, EM
Greinstetter, S
Pabinger, I
Buchacher, A
Römisch, J
Jungbauer, A
机构
[1] Univ Nat Resources & Appl Life Sci, Dept Biotechnol, A-1190 Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria
[3] Octapharma Pharmzeut Produktionsgesm bH, Vienna, Austria
关键词
epitope mapping; hemophilia A; inhibitory antibodies; solid phase peptide synthesis;
D O I
10.1016/j.jim.2005.10.016
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Epitope mapping using antibodies against factor VIII (FVIII) has been performed using blotting techniques with truncated and/or digested FVIII molecules. Here, we focused on the precise mapping of affinity purified IgG from patients with an immune response against blood clotting FVIII using synthetic peptide arrays on cellulose membranes comprising the entire sequence of FVIII. The aim was to elucidate the epitope profile from different inhibitors and possibly detect new epitopes, which have not been described before. The epitope patterns from five patients showed reactivity with all domains in the FVIII molecule, but were different between various patients. These results included epitopes usually buried within the folded protein. However, in competition assays using FVIII as competitive agent in a mixture with inhibitor IgG, the most immunogenic regions were located in the FVIII light chain. Our results show that the C1 domain was the region with highest immunogenicity in all patients. Here, we demonstrate that the SPOT method is very well suited for the precise location of epitopes in the core of the protein, which usually cannot be detected by other methods. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:90 / 100
页数:11
相关论文
共 43 条
[1]  
Dooley CT, 1998, METH MOL B, V87, P13
[2]   INCIDENCE OF DEVELOPMENT OF FACTOR-VIII AND FACTOR-IX INHIBITORS IN HEMOPHILIACS [J].
EHRENFORTH, S ;
KREUZ, W ;
SCHARRER, I ;
LINDE, R ;
FUNK, M ;
GUNGOR, T ;
KRACKHARDT, B ;
KORNHUBER, B .
LANCET, 1992, 339 (8793) :594-598
[3]  
FAY PJ, 1991, J BIOL CHEM, V266, P8957
[4]   A human alloantibody interferes with binding of factor IXa to the factor VIII light chain [J].
Fijnvandraat, K ;
Celie, PHN ;
Turenhout, EAM ;
ten Cate, JW ;
van Mourik, JA ;
Mertens, K ;
Peters, M ;
Voorberg, J .
BLOOD, 1998, 91 (07) :2347-2352
[5]  
FOSTER PA, 1990, BLOOD, V75, P1999
[6]   LOCALIZATION OF THE BINDING REGIONS OF A MURINE MONOCLONAL ANTI-FACTOR-VIII ANTIBODY AND A HUMAN ANTI-FACTOR-VIII ALLOANTIBODY, BOTH OF WHICH INHIBIT FACTOR-VIII PROCOAGULANT ACTIVITY, TO AMINO-ACID RESIDUES THREONINE-351-SERINE-365 OF THE FACTOR-VIII HEAVY-CHAIN [J].
FOSTER, PA ;
FULCHER, CA ;
HOUGHTEN, RA ;
MAHONEY, SD ;
ZIMMERMAN, TS .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (01) :123-128
[7]   SPOT-SYNTHESIS - AN EASY TECHNIQUE FOR THE POSITIONALLY ADDRESSABLE, PARALLEL CHEMICAL SYNTHESIS ON A MEMBRANE SUPPORT [J].
FRANK, R .
TETRAHEDRON, 1992, 48 (42) :9217-9232
[8]  
FULCHER CA, 1987, BLOOD, V69, P1475
[9]   LOCALIZATION OF HUMAN FACTOR-FVIII INHIBITOR EPITOPES TO 2 POLYPEPTIDE FRAGMENTS [J].
FULCHER, CA ;
MAHONEY, SD ;
ROBERTS, JR ;
KASPER, CK ;
ZIMMERMAN, TS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (22) :7728-7732
[10]   Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII [J].
Gensana, M ;
Altisent, C ;
Aznar, JA ;
Casaña, P ;
Hernández, F ;
Jorquera, JI ;
Magallón, M ;
Massot, M ;
Puig, L .
HAEMOPHILIA, 2001, 7 (04) :369-374